Ownership
Private
Employees
~53
Therapeutic Areas
OtherDentistryInfectious Diseases
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
DeviceSmall moleculeBiologicNon-pharmacological therapy

Elevate Oral Care General Information

Elevate Oral Care markets a portfolio of preventive dental products including silver diamine fluoride for caries arrest, high-fluoride varnishes and toothpastes for remineralization, dry mouth sprays, stannous fluoride rinses, xylitol-based products, patient education tools, and more. Their offerings are widely used in clinical practice with evidence-based support but do not follow the traditional drug development pipeline or clinical trial stages typical of pharmaceutical companies. The company also provides continuing education to dental professionals nationwide.

Contact Information

Primary Industry
Therapeutic Medical Devices
Corporate Office
West Palm Beach, Florida
United States

Drug Pipeline

Advantage Arrest Silver Diamine Fluoride 38%
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Elevate Oral Care's pipeline data

Book a demo

Key Partnerships

TeamSmile partnership for children's oral health outreach, CAMBRA Coalition, American Academy of Pediatric Dentistry Foundation

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Elevate Oral Care Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Elevate Oral Care's complete valuation and funding history, request access »

Elevate Oral Care Financial Metrics